Stifel Financial Corp Purchases 35,964 Shares of Tempus AI, Inc. (NASDAQ:TEM)

Stifel Financial Corp boosted its holdings in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 935.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,810 shares of the company's stock after buying an additional 35,964 shares during the quarter. Stifel Financial Corp's holdings in Tempus AI were worth $1,344,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Victory Capital Management Inc. bought a new position in Tempus AI in the 4th quarter worth approximately $216,000. China Universal Asset Management Co. Ltd. bought a new position in shares of Tempus AI in the fourth quarter worth approximately $1,091,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Tempus AI during the 4th quarter valued at about $178,000. abrdn plc bought a new position in Tempus AI in the 4th quarter worth $2,784,000. Finally, Dakota Wealth Management raised its position in shares of Tempus AI by 189.7% in the 4th quarter. Dakota Wealth Management now owns 60,668 shares of the company's stock worth $2,048,000 after acquiring an additional 39,724 shares in the last quarter. Institutional investors own 24.22% of the company's stock.

Tempus AI Trading Down 5.9 %

Shares of Tempus AI stock traded down $3.88 on Friday, reaching $61.34. 15,472,133 shares of the company were exchanged, compared to its average volume of 6,015,116. The stock has a fifty day moving average price of $48.39 and a 200-day moving average price of $51.01. The firm has a market capitalization of $10.56 billion and a price-to-earnings ratio of -7.86. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI's revenue for the quarter was up 75.4% compared to the same quarter last year. On average, analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling at Tempus AI

In other news, Director Jennifer A. Doudna sold 1,320 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $90.00, for a total value of $118,800.00. Following the transaction, the director now owns 36,011 shares of the company's stock, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Ryan M. Bartolucci sold 6,059 shares of the firm's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $80.00, for a total value of $484,720.00. Following the transaction, the chief accounting officer now owns 47,000 shares in the company, valued at approximately $3,760,000. This trade represents a 11.42 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 4,237,561 shares of company stock worth $251,210,331. Insiders own 27.60% of the company's stock.

Analyst Upgrades and Downgrades

TEM has been the subject of several research analyst reports. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Morgan Stanley increased their price target on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday. BTIG Research assumed coverage on Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 target price on the stock. Bank of America lifted their target price on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. Finally, Loop Capital decreased their price objective on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research note on Tuesday, January 14th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Tempus AI currently has an average rating of "Moderate Buy" and an average price target of $61.50.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.